Sort by
Refine Your Search
-
supervision by ETH Zurich and Roche principal investigators Infrastructure: full access to world-class facilities at both the Roche and ETH Zurich campuses in Basel Development: a fully funded 2-year fellowship
-
, and peptide chemistry are welcome but not essential Profile A highly-motivated student who has completed a Master's degree in chemistry or a similar field Able to work independently on your own project
-
the research infrastructure of the ETH Zurich Disseminate research results in peer-reviewed journal articles and at international conferences Profile Essential experience, skills and characteristics: A master's
-
, safety, and societal acceptance of CO₂ injection into Switzerland's subsurface. Time-lapse seismic-reflection imaging is the primary tool to image the CO₂ plume and its migration through the subsurface
-
for Master degree, certificate of doctoral degree) Two reference letters Further information about the Department Biosystems Science and Engineering can be found on our Website . Information about the gorup
-
control applications in offshore wind energy contexts. This position is offered for 36 months, with the earliest starting date as agreed upon recruitment. The primary academic advisor is Prof. Eleni Chatzi
-
analysis of primary and secondary data, in both controlled and field settings. The successful candidate will shape projects and research questions within this overarching scope, whilst working alongside
-
We are looking for candidates with one of the two profiles below, aligned with our lab’s main research branches. 1. Mathematical foundations of trustworthy ML - working on topics such as: (Robust
-
aims to answer the following main research questions: R1: How is the system security affected if the system is organized into regional frequency balancing zones instead of national, independent zones
-
Engineering, ETH Zurich, Basel) and the University Hospital Heidelberg / German Cancer Research Center (Heidelberg, Germany). Project background Glioblastoma (GB) is the most aggressive primary brain cancer in